Preclinical models for pulmonary drug delivery

Author： Fernandes Cláudia A   Vanbever Rita  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.6, Iss.11, 2009-11, pp. : 1231-1245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biodegradable polymeric nanocarriers for pulmonary drug delivery

By Rytting Erik   Nguyen Juliane   Wang Xiaoying   Kissel Thomas  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 6, 2008-06 ,pp. : 629-639

Informa Healthcare

Access to resources Recommend Favorite

Dry powder inhalers for pulmonary drug delivery

By Frijlink H W   De Boer A H  

Expert Opinion on Drug Delivery, Vol. 1, Iss. 1, 2004-11 ,pp. : 67-86

Informa Healthcare

Access to resources Recommend Favorite

Paediatric pulmonary drug delivery: considerations in asthma treatment

By Berger William E  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 6, 2005-11 ,pp. : 965-980

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary insulin delivery by means of the Technosphere™ drug carrier mechanism

By Pfützner Andreas   Forst Thomas  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 6, 2005-11 ,pp. : 1097-1106

Informa Healthcare

Access to resources Recommend Favorite

Propellant-driven metered-dose inhalers for pulmonary drug delivery

By Smyth Hugh DC  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 1, 2005-01 ,pp. : 53-74

Informa Healthcare

Access to resources Recommend Favorite